Literature DB >> 1138539

A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus.

D A Horwitz, J B Cousar.   

Abstract

Eighteen newly diagnosed, untreated patients with systemic lupus erythematosus (SLE) were divided into two groups based on the severity of the disease. Patients with very active disease were nonresponsive to skin test antigens used to assess delayed hypersensitivity. Skin test reactivity was intact in most patients with mildly active disease. Lymphocytes from subjects in both groups responded normally to phytohemagglutinin (PHA) when the results were expressed as counts per minute per million small lymphocytes. Serum from patients with severely active disease markedly suppressed lymphocyte responsiveness of autologous and allogeneic lymphocytes. Serum from patients with mild disease had significantly less suppressor activity. Lymphocytotoxic antibodies and suppressor activity were not correlated. Suppressor activity in immunoglobulin G fraction paralleled that found in whole serum. The present studies suggest that impaired delayed whole serum. The present studies suggest that impaired delayed hypersensitivity in SLE is a consequence of disease activity rather than an inherent feature of this disease. The strong correlation between serum suppression of PHA reactivity and anergy suggests that the humoral immunosuppressive effects described may be responsible, in part, for impaired delayed hypersensitivity in this disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138539     DOI: 10.1016/0002-9343(75)90639-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Antibodies for T lymphocytes in systemic lupus erythematosus.

Authors:  G Michlmayr; C Pathouli; C Huber; H Huber
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

Review 2.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

3.  T-cell adhesion to endothelial cells in systemic lupus erythematosis.

Authors:  D O Haskard; D Cavender; D Maliakkal; M Ziff
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

5.  Cloning of T-lymphocytes in systemic lupus erythematosus.

Authors:  S Whittingham; B Rodger; J V Matthews; I R Mackay
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

6.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  NK cell activity and skin test antigen stimulation of NK like CMC in vitro are decreased to different degrees in pregnancy and sarcoidosis.

Authors:  D Tartof; J J Curran; S L Yang; C Livingston
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Suppressor effects of histamine on SK/SD delayed hypersensitivity reactions in man and on E-rosette-forming cells.

Authors:  U Ambanelli; G F Ferraccioli; P Mangenelli; G L Vanona
Journal:  Agents Actions       Date:  1979-12

9.  The pathogenesis of neuropsychiatric lupus.

Authors:  J A Denburg; P Temesvari
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

10.  T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; K Tanimoto; Y Horiuchi; R C Williams
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.